| Ikuko Laccheo, MD | |
|
229 William Claiborne, Williamsburg, VA 23185-6528 | |
| (888) 464-2466 | |
| (410) 740-1518 |
| Full Name | Ikuko Laccheo |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 17 Years |
| Location | 229 William Claiborne, Williamsburg, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255539797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 0101254625 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Community Hospital | Munster, IN | Hospital |
| New England Baptist Hospital | Boston, MA | Hospital |
| Medstar Georgetown University Hospital | Washington, DC | Hospital |
| Regional Medical Center Bayonet Point | Hudson, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Neuromonitoring Associates Pc | 8022019710 | 28 |
News Archive
Portola Pharmaceuticals, Inc. today announced two oral presentations at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain, that will feature its investigational antiplatelet drug elinogrel, a P2Y12 ADP receptor antagonist that is currently in Phase II clinical development with Novartis, Portola's development and commercialization partner.
Responding to the needs of the country's growing older adult population, a new collaborative best practices guideline was released today for optimal care of older adults immediately before, during, and after surgical operations (a timeframe known as the "perioperative" period).
Although some data have suggested that supplementation with soy isoflavone may be an effective treatment for patients with poor asthma control, a randomized trial that included nearly 400 children and adults found that use of the supplement did not result in improved lung function or clinical outcomes, including asthma symptoms and episodes of poor asthma control, according to a study in the May 26 issue of JAMA.
Advanzeon Solutions, Inc., which provides behavioral health, substance abuse and pharmacy management services, as well as sleep apnea programs, to employers, Taft-Hartley health and welfare funds, and managed care companies throughout the U.S. is pleased to announce that it has entered into an Agreement with WLT Software Enterprises, Inc.
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.
› Verified 5 days ago
| Entity Name | American Neuromonitoring Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740391283 PECOS PAC ID: 8022019710 Enrollment ID: O20090409000526 |
News Archive
Portola Pharmaceuticals, Inc. today announced two oral presentations at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain, that will feature its investigational antiplatelet drug elinogrel, a P2Y12 ADP receptor antagonist that is currently in Phase II clinical development with Novartis, Portola's development and commercialization partner.
Responding to the needs of the country's growing older adult population, a new collaborative best practices guideline was released today for optimal care of older adults immediately before, during, and after surgical operations (a timeframe known as the "perioperative" period).
Although some data have suggested that supplementation with soy isoflavone may be an effective treatment for patients with poor asthma control, a randomized trial that included nearly 400 children and adults found that use of the supplement did not result in improved lung function or clinical outcomes, including asthma symptoms and episodes of poor asthma control, according to a study in the May 26 issue of JAMA.
Advanzeon Solutions, Inc., which provides behavioral health, substance abuse and pharmacy management services, as well as sleep apnea programs, to employers, Taft-Hartley health and welfare funds, and managed care companies throughout the U.S. is pleased to announce that it has entered into an Agreement with WLT Software Enterprises, Inc.
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ikuko Laccheo, MD 10275 Little Patuxent Pkwy Ste 300, Columbia, MD 21044-3445 Ph: (888) 464-2466 | Ikuko Laccheo, MD 229 William Claiborne, Williamsburg, VA 23185-6528 Ph: (888) 464-2466 |
News Archive
Portola Pharmaceuticals, Inc. today announced two oral presentations at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain, that will feature its investigational antiplatelet drug elinogrel, a P2Y12 ADP receptor antagonist that is currently in Phase II clinical development with Novartis, Portola's development and commercialization partner.
Responding to the needs of the country's growing older adult population, a new collaborative best practices guideline was released today for optimal care of older adults immediately before, during, and after surgical operations (a timeframe known as the "perioperative" period).
Although some data have suggested that supplementation with soy isoflavone may be an effective treatment for patients with poor asthma control, a randomized trial that included nearly 400 children and adults found that use of the supplement did not result in improved lung function or clinical outcomes, including asthma symptoms and episodes of poor asthma control, according to a study in the May 26 issue of JAMA.
Advanzeon Solutions, Inc., which provides behavioral health, substance abuse and pharmacy management services, as well as sleep apnea programs, to employers, Taft-Hartley health and welfare funds, and managed care companies throughout the U.S. is pleased to announce that it has entered into an Agreement with WLT Software Enterprises, Inc.
Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.
› Verified 5 days ago
Dr. Syed Zafar Ahsan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1657 Merrimac Trl, Williamsburg, VA 23185 Phone: 757-220-3200 Fax: 757-253-4013 | |
Dr. Margaret Hale Vincent, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1657 Merrimac Trl, Williamsburg, VA 23185 Phone: 757-220-3200 | |
Akriti Sinha, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4601 Ironbound Rd, Williamsburg, VA 23188 Phone: 757-253-5161 Fax: 757-253-5065 | |
Shawke A Soueidan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 2700, Williamsburg, VA 23185 Phone: 757-221-0110 Fax: 757-221-0851 | |
Dr. Chan Nguyen, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4601 Ironbound Rd, Williamsburg, VA 23188 Phone: 757-253-5347 Fax: 757-253-5319 | |
Dr. Avtar S Dhillon, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5483 Mooretown Road, Williamsburg, VA 23188 Phone: 757-941-6400 Fax: 757-941-6419 | |
Paul Reilly, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1115 Old Colony Ln, Williamsburg, VA 23185 Phone: 757-253-0691 Fax: 757-220-9571 |